Improving lung cancer treatment through targeted therapies
Targeting Integrins in Lung Cancer
This study is looking for better ways to help people with advanced lung cancer by creating easy blood tests that can find specific markers in their tumors, so doctors can choose the best treatments and see how well they’re working.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Northern California Health Care Sys NIH-funded |
| Lab location | 1 site (Mather, United States) |
| Project ID | NIH-10768639 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of lung cancer by developing new methods to identify and target specific biomarkers in patients. It aims to create sensitive and cost-effective assays that can detect tumor-specific and immune cell-specific markers using simple blood tests. By analyzing biofluid samples from patients with advanced non-small cell lung cancer (NSCLC), the study seeks to improve the selection of appropriate therapies and monitor treatment responses more effectively. The goal is to increase the percentage of patients who benefit from targeted therapies and immunotherapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with advanced non-small cell lung cancer (NSCLC).
Not a fit: Patients with early-stage lung cancer or those with other types of cancer may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes for lung cancer patients by enabling more personalized and effective therapy selection.
How similar studies have performed: Previous research has shown promise in using targeted therapies and biomarker identification in cancer treatment, indicating that this approach could lead to meaningful advancements.
Where this research is happening
Mather, United States
- VA Northern California Health Care Sys — Mather, United States (Active)
Researchers
- Principal investigator: Li, Tianhong — VA Northern California Health Care Sys
- Study coordinator: Li, Tianhong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.